Management of COVID-19: Other drugs and convalescent plasma

M. Patout (Mont-Saint Aignan, France)

Source: ERS Course 2021 - COVID-19: State of the art
Number: 9


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Patout (Mont-Saint Aignan, France). Management of COVID-19: Other drugs and convalescent plasma. ERS Course 2021 - COVID-19: State of the art

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Other drugs and convalescent plasma
Source: Virtual Congress 2020 – Management
Year: 2020

Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives
Source: ERS webinar 2020: Convalescent plasma therapy in COVID-19 patients: Chinese and European perspectives
Year: 2020

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma
Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021
Year: 2022

Addition of convalescent plasma to systemic corticosteroids in early phase of COVID-19
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021

Convalescent plasma for SARS-CoV-2 infection: win or learn
Source: Eur Respir J, 59 (2) 2102076; 10.1183/13993003.02076-2021
Year: 2022

The efficacy of convalescent plasma therapy in severe COVID-19 patients: a systematic review
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Year: 2021

Anti-tuberculosis drug concentrations and treatment outcomes in patients with both tuberculosis and HIV infection
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients
Source: Virtual Congress 2021 – COVID - 19 treatments
Year: 2021

Changes in plasma pyridoxal levels during standard treatment tuberculosis
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Serum acute phase reactants in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 312s
Year: 2002

Evaluation of drug induced liver injury due to anti tuberculous drugs in directly observed daily therapy
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

CVA: serum ECP in the management of steroid therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013

Blood and urine IP-10 associate with active TB in HIV-infected patients
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016

Oral human serum immunoglobulin for norovirus diarrhea in pulmonary transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014

Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

Serum YKL-40 is elevated in children with pneumonia and RSV infection
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014

Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection
Source: Eur Respir J 2013; 42: 547-550
Year: 2013

Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010